SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Axe Compute, Inc. engages in the application of artificial intelligence medicine and the provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal, and associated products. It operates through the following segments: Helomics, zPREDICTA, Skyline, Soluble, and Corporate. The Helomics segment includes contract services that include the application of AI, partnering projects, and clinical testing. The zPREDICTA segment specializes in organ-specific disease models that provide 3D reconstruction of human tissues accurately representing each disease state and mimicking drug response enabling accurate testing of anticancer agents. The Skyline segment consists of the STREAMWAY System product sales, and its TumorGenesis subsidiary is included within the Corporate segment. The Soluble segment provides services using an automated system that conducts self-interaction chromatography screens, using additives and excipients commonly included in protein formulations resulting in soluble and physically stable formulations for biologics. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Pittsburgh, PA.

Axe Compute Inc.

Predictive Oncology Inc

Predictive Oncology Inc. is trending after announcing a significant private placement to initiate a digital asset treasury strategy focused on Aethir (ATH) tokens, signaling a strategic pivot towards high-performance AI infrastructure. This development, occurring alongside a reverse stock split and an impending ticker change to AGPU, has sparked intense debate among investors, with some anticipating a high-potential low-float crypto play while others express deep skepticism due to the company's history of dilution and previous business shifts.

USA Rare Earth, Inc. is domestic supplier of rare earth magnets and heavy rare earth elements. It is developing a vertically integrated, domestic supply chain for rare earth element magnet production, with a facility in Stillwater, Oklahoma, and mining rights to the Round Top heavy rare earth and critical minerals deposit in West Texas. The company was founded in May 2019 and is headquartered in Stillwater, OK.

USA Rare Earth Inc. - Ordinary Shares - Class A

USA Rare Earth Inc

USA Rare Earth (USAR) is generating significant buzz following a substantial $1.6 billion investment from the U.S. government for a 10% equity stake, complemented by a $1.3 billion loan. This strategic move aims to bolster domestic rare earth supply chains, with the community actively discussing potential for considerable stock appreciation and a short squeeze, while also seeing it as a broad validation for the entire critical minerals sector. Further news of a new rare earth processing plant in France, backed by government support, reinforces USAR's expanding role in establishing independent global rare earth production.

CPS Technologies Corp. engages in the provision of advanced material solutions to the transportation, automotive, energy, computing or Internet, telecommunications, aerospace, defense, and oil and gas end markets. The firm focuses on the design, manufacture, and sale of custom metal matrix composite components. It also assembles housings and packages for hybrid circuit. The company was founded in 1984 and is headquartered in Norton, MA.

CPS Technologies Corporation

CPS Technologies is trending amid strong community anticipation for significant contract updates and material news, with recent discussion focusing on its critical role in defense, nuclear energy, and AI data center infrastructure. Investors are highlighting the company's multiple US government contracts and its strategic positioning with advanced composite materials as key drivers for potential future growth. Chatter around increased insider buying and a planned facility expansion further bolsters confidence in its long-term prospects.

Palvella Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which focuses on developing and commercializing novel therapies to treat patients suffering from serious, rare genetic skin diseases for which there are no FDA-approved therapies. It develops a pipeline of treatments for rare genetic skin diseases using its patented QTORIN platform. The company was founded in 2015 and is headquartered in Wayne, PA.

Palvella Therapeutics Inc.

Palvella Therapeutics Inc

Palvella Therapeutics is generating significant buzz following positive Phase 2 trial results for its QTORIN rapamycin gel in cutaneous venous malformations, a rare skin condition with no approved treatments. This clinical success, coupled with a recent Fast Track designation and a "pipeline-in-a-product" strategy targeting multiple rare dermatological indications, is driving numerous analyst upgrades and high price targets. The community is actively debating the stock's future, weighing potential dilution against the substantial market opportunity and upcoming Phase 3 data for another indication.

Caterpillar, Inc. engages in the business of manufacturing construction and mining equipment, off-highway diesel and natural gas engines, industrial gas turbines, and diesel-electric locomotives. It operates through the following segments: Construction Industries, Resource Industries, Energy and Transportation, Financial Products, and All Other. The Construction Industries segment is involved in supporting customers using machinery in infrastructure and building construction applications. The Resource Industries segment offers machinery in mining, heavy construction, quarry, and aggregates. The Energy and Transportation segment focuses on reciprocating engines, turbines, diesel-electric locomotives, and related services across industries serving oil and gas, power generation, industrial, and transportation applications including marine- and rail-related businesses. The Financial Products segment provides financing alternatives to customers and dealers for Caterpillar products and services, as well as financing for power generation facilities. The All Other segment includes activities such as the business strategy, product management and development, manufacturing, and sourcing of wear and maintenance components products, parts distribution, integrated logistics solutions, distribution services responsible for dealer development, and administration. The company was founded on April 15, 1925 and is headquartered in Irving, TX.

Caterpillar Inc.

Caterpillar is trending due to its unexpected emergence as a key beneficiary of the AI infrastructure boom, with its power generation and energy solutions segment experiencing surging demand from data centers. This pivot from traditional heavy machinery to critical energy supplier has led analysts to significantly raise price targets, prompting robust community discussion about the company's re-rated valuation and long-term prospects beyond its traditional heavy machinery segments.

Standard Lithium Ltd. engages in the testing and proving of the commercial viability of lithium extraction. Its projects include Arkansas Lithium, Lithium Brine Processing, and California Lithium. The company was founded by Alvaro Anthony on August 14, 1998 and is headquartered in Vancouver, Canada.

Standard Lithium Ltd

Standard Lithium is a hot topic as it advances its Arkansas lithium projects with strong U.S. government backing, including recent fast-tracking and grant funding, reinforcing its role in the domestic critical minerals supply. The community is actively discussing the potential of its DLE technology and the broader sector tailwinds of rising lithium prices and demand, anticipating significant long-term value.

Achieve Life Sciences, Inc. is a clinical-stage pharmaceutical company, which engages in the development and commercialization of cytisinicline for smoking cessation. Its products includes cytisine, a plant-based alkaloid with a binding affinity to the nicotinic acetylcholine receptor. The company was founded in October 1991 and is headquartered in Vancouver, Canada.

Achieve Life Sciences Inc.

Achieve Life Sciences is gaining significant attention following its cytisinicline receiving an FDA National Priority Voucher for vaping cessation, enabling an expedited review, alongside the FDA's acceptance of its smoking cessation New Drug Application with a June 2026 PDUFA date. The community is actively discussing potential M&A interest from larger pharmaceutical companies, citing the drug's strong efficacy and safety profile and its potential to become a leading therapy for nicotine dependence.

Fidelity Wise Origin Bitcoin Fund - Fidelity Wise Origin Bitcoin Fund Beneficial Interest

Fidelity Wise Origin Bitcoin Fund

FBTC is actively trending as Bitcoin ETFs experience significant, though sometimes volatile, capital flows, with institutions and individual investors keenly observing the dynamic market. The community is split on Bitcoin's immediate price trajectory, with some traders navigating short-term volatility while others express strong conviction for long-term accumulation, viewing it as a key asset in evolving portfolios. This reflects ongoing discussions about Bitcoin's role amidst growing institutional adoption and broader macroeconomic signals.

Zoracles

Zoracles (ZORA) is trending as the crypto community anticipates a significant rebound and the broader 'ALT coin season.' Investors are actively 'loading' more, driven by its role in the creator economy and its connection to Coinbase's Base ecosystem. The upcoming 'Clarity Act' is a major talking point, viewed as a catalyst to bring regulatory legitimacy and fresh capital into the altcoin space.

Praxis Precision Medicines, Inc. is a clinical-stage biopharmaceutical company, which engages in the genetic epilepsies into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal excitation-inhibition imbalance. It focuses on two proprietary platforms: Cerebrum and Solidus. The Cerebrum platform utilizes a deep understanding of neuronal excitability and neuronal networks and applies a series of computational and experimental tools to develop orally available precision therapies. The Solidus platform consists of antisense oligonucleotide, or ASO. The company was founded by Kiran Reddy, David Goldstein, and Steven Petrou on September 22, 2015 and is headquartered in Boston, MA.

Praxis Precision Medicines Inc

Praxis Precision Medicines is trending due to positive clinical data for its essential tremor treatment, ulixacaltamide, which recently received FDA Breakthrough Therapy Designation, and early efficacy results for an epilepsy drug. This has led to numerous analyst upgrades and discussions about large market potential, though some investors are also weighing the impact of recent share offerings on valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Peabody to Announce Results for the Fourth Quarter and Year Ended December 31, 2025

Peabody to Announce Results for the Fourth Quarter and Year Ended December 31, 2025 Peabody to Announce Results for the Fourth Quarter and Year Ended December 31, 2025 PR Newswire ST. LOUIS, Jan. 21...

Peabody Energy (NYSE:BTU) Sets New 12-Month High on Analyst Upgrade

Peabody Energy (NYSE:BTU) Hits New 12-Month High on Analyst Upgrade...

Peabody Energy (NYSE:BTU) Price Target Raised to $44.00 at Jefferies Financial Group

Jefferies Financial Group increased their price target on Peabody Energy from $42.00 to $44.00 and gave the stock a "buy" rating in a research report on Tuesday...

Peabody Energy (NYSE:BTU) CAO Scott Jarboe Sells 2,151 Shares of Stock

Peabody Energy Corporation (NYSE:BTU - Get Free Report) CAO Scott Jarboe sold 2,151 shares of Peabody Energy stock in a transaction that occurred on Wednesday, January 14th. The shares were sold at...

Nwam LLC Takes $2.40 Million Position in Peabody Energy Corporation $BTU

Nwam LLC acquired a new position in Peabody Energy Corporation (NYSE:BTU - Free Report) in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange...

Peabody's President and Chief Executive Officer Jim Grech Named Chair of National Coal Council

Peabody's President and Chief Executive Officer Jim Grech Named Chair of National Coal Council Peabody's President and Chief Executive Officer Jim Grech Named Chair of National Coal Council PR...

Peabody Energy (NYSE:BTU) Sets New 52-Week High - Here's What Happened

Peabody Energy (NYSE:BTU) Reaches New 1-Year High - Should You Buy...

Peabody Energy (NYSE:BTU) Rating Lowered to "Sell" at Wall Street Zen

Wall Street Zen cut Peabody Energy from a "hold" rating to a "sell" rating in a research note on Sunday...

Peabody Energy Corporation $BTU Shares Purchased by Geneos Wealth Management Inc.

Geneos Wealth Management Inc. boosted its position in shares of Peabody Energy Corporation (NYSE:BTU - Free Report) by 20,358.0% during the third quarter, according to its most recent Form 13F filing...

Zacks Industry Outlook Highlights Warrior Met, Peabody Energy and Ramaco 

Warrior Met, Peabody Energy and Ramaco have been highlighted in this Industry Outlook article.


Peabody Energy Corp. engages in the business of coal mining. It operates through the following business segments: Seaborne Thermal, Seaborne Metallurgical, Powder River Basin, Other U.S. Thermal, and Corporate and Other. The Seaborne Thermal segment consist of mines in New South Wales, Australia. The Seaborne Metallurgical segment includes mines in Queensland, Australia, one in New South Wales, Australia and one in Alabama, USA. The Powder River Basin segment focuses on mines in Wyoming. The Other U.S. Thermal segment reflects on the mining, preparation and sale of thermal coal, sold primarily to electric utilities in the U.S. under long-term contracts, with a relatively small portion sold as international exports as conditions warrant. The Corporate and Other segment involves administrative expenses, results from equity method investments, trading and brokerage activities, minimum charges on certain transportation-related contracts, the closure of inactive mining sites, the impact of foreign currency remeasurement and certain commercial matters. The company was founded by Francis S. Peabody in 1883 and is headquartered in St. Louis, MO.

Peabody Energy Corp. - Ordinary Shares New

$MSFT

$AAPL

$TSLA

$META

Earnings season is heating up, and several major companies report next week, including Microsoft, Apple, Tesla, and Meta. Which are you most excited for?

Which earnings report are you most excited for next week? 
 
Drop a comment for others.

Current Price	$37.96
Prev Close	$38.52
Open	$38.56
Dividend Yield	1.43%
50-Day Moving Average	$30.53
Beta	0.93
Avg. Volume	2.49M
PE Ratio	-131.03

52-Week High	$39.95
52-Week Low	$9.61
Market Capitalization	$6.25B
EPS (Annual)	$2.70
Price to Book	1.30
Revenue Per Employee	$756,553.57
Enterprise Value/EBITDA	N/A

BTU
Peabody Energy Corp. - Ordinary Shares New

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BTU News

BTUPeabody Energy Corp. - Ordinary Shares New